Theratechnologies Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2024 12 months to Nov 30, 2024	FY2023 12 months to Nov 30, 2023	FY2022 12 months to Nov 30, 2022	FY2021 12 months to Nov 30, 2021	FY2020 12 months to Nov 30, 2020
Cash flows from (used in) Operating
Net loss
Adjustments for
Depreciation of property and equipment
Amortization of intangible assets and other asset
Amortization of right-of-use assets
Share-based compensation for stock option plan and stock appreciation rights
(Reversal) write-down of inventories
Impairment loss on intangible assets
Change in fair value of derivative financial assets
Change in fair value of liability related to deferred stock unit plan
Interest on convertible unsecured senior notes
Interest on convertible unsecured senior notes and long-term debt
Interest paid on convertible unsecured senior notes and long-term debt
Interest income
Interest received
Income tax expense
Deferred revenue
Federal investment tax credits
Income taxes paid
Foreign exchange
Accretion expense
Gain on repurchase of convertible unsecured senior notes
Accretion expense and amortization of deferred financing costs
Accretion expense, write-off, amortization of deferred financing costs and other
Change in fair value of Marathon Warrants
Write off of deferred financing costs
Loss on long-term debt modifications and repayment
Cash flows from (used in) operations before changes in working capital

Change in operating assets and liabilities
Trade and other receivables
Tax credits receivable
Inventories
Prepaid expenses and deposits
Accounts payable and accrued liabilities
Provisions
Deferred revenue
Increase (decrease) in working capital
Total cash from (used) in operating activities
Financing activities
Repayment of long-term obligations
Repurchase of convertible unsecured senior notes
Costs related to repurchase of convertible unsecured senior notes
Proceeds from issuance of long-term debt
Costs related to issuance of long-term debt
Repayment of other obligations
Repayment of long-term debt
Costs related to repayment of long-term debt
Proceeds from exercise of Options
Proceeds from exercise of warrants
Proceeds from issue of common shares, Public Offering Warrants and subscription receipts
Costs related to issuance of common shares, Public Offering Warrants and subscription receipts
Interest paid on convertible unsecured senior notes
Deferred financing costs
Payment of lease liability
Total cash (used in) from financing activities

Investing activities
Acquisition of intangible assets
Acquisition of property and equipment
Proceeds from sale of bonds and money market funds
Acquisition of bonds and money market funds
Interest received
Acquisition of derivative financial assets
Other
Total cash from investing activities

Net change in cash
Cash, beginning of year
Effect of foreign exchange on cash
Cash and cash equivalent held in escrow, end of year

Comments